Crespo Escobar Paula, Castillejo Gemma, Martínez-Ojinaga Eva, Donat Ester, Polanco Isabel, Mearin María Luisa, Ribes-Koninckx Carmen
Unidad de Enfermedad Celiaca e Inmunopatología Dig, Instituto de Investigación Sanitaria la Fe, España.
Hospital Universitari Sant Joan, Reus y Universitat Rovira i Virgili, España.
Rev Esp Enferm Dig. 2018 Aug;110(8):493-499. doi: 10.17235/reed.2018.5324/2017.
to evaluate the influence of gluten consumption on celiac disease development and to describe its natural history in the Spanish cohort of the European PreventCD study.
prospective multi-center double blind study of 225 children that were followed up from birth. All cases were HLA-DQ2/HLA-DQ8 positive with a 1st degree relative with celiac disease and were followed up in three centers from Madrid, Reus and Valencia. Gluten intake was determined between four and ten months according to the protocol. Gluten intake was ad libitum between eleven and 36 months and was prospectively quantified by means of dietary records. Clinical visits and specific antibody analysis for celiac disease were performed periodically.
twenty-six cases were diagnosed, all had a positive biopsy and serology; 21 had gastrointestinal symptoms and five were asymptomatic. In addition, 2,565 food records were analyzed and statistically significant differences (p < 0.001) were found with regard to gluten consumption among the three centers, although not between celiac and non-celiac children (p = 0.025). The HLA-DQ2.5/DQ2.5 and DQ2.5/DQ2.2 genotypes had a relative risk of 4.7 (95% CI: 0.80-27.55; p = 0.08), which was higher than for the rest of genotypes. Female gender also had a relative risk that was five times higher than that for males.
the amount of gluten intake between 11 and 36 months or the duration of breast feeding were not risk factors for the development of CD in the Spanish population. The HLA genotype and gender were the most relevant associated factors. In this at-risk group, the disease presented before two years of age in the majority of the cases with a weak clinical expression.
评估麸质摄入对乳糜泻发展的影响,并描述其在欧洲预防乳糜泻研究的西班牙队列中的自然病史。
对225名从出生就开始随访的儿童进行前瞻性多中心双盲研究。所有病例均为HLA-DQ2/HLA-DQ8阳性,且有一名患乳糜泻的一级亲属,并在马德里、雷乌斯和巴伦西亚的三个中心进行随访。根据方案在4至10个月时确定麸质摄入量。11至36个月时随意摄入麸质,并通过饮食记录进行前瞻性定量。定期进行临床检查和乳糜泻特异性抗体分析。
确诊26例,活检和血清学均呈阳性;21例有胃肠道症状,5例无症状。此外,分析了2565份食物记录,发现三个中心之间在麸质摄入量方面存在统计学显著差异(p<0.001),但乳糜泻患儿与非乳糜泻患儿之间无差异(p = 0.025)。HLA-DQ2.5/DQ2.5和DQ2.5/DQ2.2基因型的相对风险为4.7(95%CI:0.80-27.55;p = 0.08),高于其他基因型。女性的相对风险也比男性高五倍。
11至36个月期间的麸质摄入量或母乳喂养时间不是西班牙人群患乳糜泻的危险因素。HLA基因型和性别是最相关的关联因素。在这个高危人群中,大多数病例在两岁前发病,临床表现较轻。